O00422
Gene name |
SAP18 (GIG38) |
Protein name |
Histone deacetylase complex subunit SAP18 |
Names |
18 kDa Sin3-associated polypeptide, 2HOR0202, Cell growth-inhibiting gene 38 protein, Sin3-associated polypeptide p18 |
Species |
Homo sapiens (Human) |
KEGG Pathway |
hsa:10284 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
2 structures for O00422
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| 2HDE | NMR | - | A | 6-149 | PDB |
| AF-O00422-F1 | Predicted | AlphaFoldDB |
82 variants for O00422
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
|
rs752464689 CA6907632 |
4 | E>V | No |
ClinGen ExAC gnomAD |
|
|
CA387494914 rs1161977637 |
5 | S>* | No |
ClinGen TOPMed |
|
|
CA387494909 rs1379939952 |
5 | S>T | No |
ClinGen gnomAD |
|
|
CA387494922 rs777404407 |
6 | R>C | No |
ClinGen ExAC gnomAD |
|
|
CA387494924 rs1265831715 |
6 | R>H | No |
ClinGen gnomAD |
|
|
rs777404407 CA6907634 |
6 | R>S | No |
ClinGen ExAC gnomAD |
|
|
rs1418054147 CA387494974 |
10 | E>G | No |
ClinGen gnomAD |
|
|
CA387495011 rs1487229594 |
13 | K>R | No |
ClinGen gnomAD |
|
|
CA6907636 rs757198379 |
17 | E>D | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA gnomAD |
|
CA387495068 rs1156759952 |
18 | K>E | No |
ClinGen gnomAD |
|
|
CA6907637 rs550761091 |
18 | K>N | No |
ClinGen ExAC gnomAD |
|
|
CA6907638 rs745325674 |
19 | P>S | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA387495151 rs1490307670 |
22 | R>L | No |
ClinGen TOPMed |
|
|
rs1267218087 CA387495173 |
24 | K>T | No |
ClinGen TOPMed |
|
|
rs1455361158 CA387495563 |
25 | T>P | No |
ClinGen gnomAD |
|
|
CA387495648 rs1210721036 |
30 | L>P | No |
ClinGen TOPMed |
|
|
CA387495723 rs1347601736 |
35 | T>I | No |
ClinGen gnomAD |
|
|
rs771411837 CA6907704 |
36 | N>S | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA387495771 rs1351411347 |
40 | H>Y | No |
ClinGen gnomAD |
|
|
rs1206989775 CA387495808 |
43 | M>I | No |
ClinGen gnomAD |
|
|
rs1595288059 CA387495800 |
43 | M>L | No |
ClinGen Ensembl |
|
|
CA387495823 rs1290210041 |
44 | D>E | No |
ClinGen gnomAD |
|
|
CA387495846 rs1490340812 |
46 | F>L | No |
ClinGen gnomAD |
|
|
CA6907706 rs757818539 |
47 | S>C | No |
ClinGen ExAC |
|
|
CA387495860 rs1271435407 |
48 | R>Q | No |
ClinGen gnomAD |
|
|
CA6907707 rs781593093 |
48 | R>W | No |
ClinGen ExAC gnomAD |
|
|
CA387495879 rs1565985582 |
50 | N>S | No |
ClinGen Ensembl |
|
|
CA6907709 rs769823450 |
51 | V>G | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs775710122 CA6907710 |
52 | P>R | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs1804868 CA246587474 |
52 | P>T | No |
ClinGen Ensembl |
|
|
CA387495900 rs1364856311 |
53 | S>T | No |
ClinGen gnomAD |
|
|
rs1304907056 CA387495915 |
54 | S>T | No |
ClinGen gnomAD |
|
| TCGA novel | 55 | E>K | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs1306492238 CA387495948 |
57 | Q>E | No |
ClinGen gnomAD |
|
|
rs1336638264 CA387495956 |
58 | I>V | No |
ClinGen gnomAD |
|
|
rs1185009308 CA387496077 |
62 | M>V | No |
ClinGen TOPMed |
|
|
CA246592292 rs954845353 |
73 | V>A | No |
ClinGen TOPMed |
|
| TCGA novel | 73 | V>I | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
| TCGA novel | 74 | K>N | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs968775589 CA246592300 |
75 | E>D | No |
ClinGen Ensembl |
|
|
CA246592299 rs1021730701 |
75 | E>V | No |
ClinGen Ensembl |
|
|
CA6907730 rs749330807 |
76 | V>I | No |
ClinGen ExAC gnomAD |
|
|
CA387496237 rs1396811280 |
84 | G>D | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
ClinGen Ensembl NCI-TCGA |
|
rs748376383 CA6907733 |
85 | T>I | No |
ClinGen ExAC gnomAD |
|
|
rs1330254667 CA387496252 |
86 | H>Y | No |
ClinGen TOPMed gnomAD |
|
|
CA387496265 rs1292926263 |
87 | F>L | No |
ClinGen TOPMed |
|
|
rs1481838912 CA387496276 |
88 | N>H | No |
ClinGen gnomAD |
|
|
CA6907734 rs770685260 |
88 | N>S | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA6907735 rs776479725 |
89 | F>S | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA gnomAD |
|
CA6907736 rs759393970 |
91 | I>V | No |
ClinGen ExAC gnomAD |
|
|
CA387496321 rs1184964859 |
92 | V>I | No |
ClinGen gnomAD |
|
|
CA387496346 rs1417292145 |
94 | T>A | No |
ClinGen gnomAD |
|
|
CA6907737 rs769673358 |
95 | D>N | No |
ClinGen ExAC gnomAD |
|
|
CA387496401 rs1468041449 |
99 | P>H | No |
ClinGen gnomAD |
|
|
CA6907738 rs775015278 |
100 | G>V | No |
ClinGen ExAC gnomAD |
|
|
CA387496419 rs1405698390 |
101 | Y>C | No |
ClinGen gnomAD |
|
|
CA6907739 rs762493934 |
102 | R>* | No |
ClinGen ExAC gnomAD |
|
|
rs763576966 CA6907740 |
102 | R>Q | No |
ClinGen ExAC TOPMed |
|
|
rs1029458992 CA246592710 |
106 | I>M | No |
ClinGen gnomAD |
|
|
rs1403487127 CA387496514 |
106 | I>V | No |
ClinGen gnomAD |
|
|
rs1224924349 CA387496539 |
108 | S>I | No |
ClinGen gnomAD |
|
|
rs768222752 CA6907760 |
112 | G>V | No |
ClinGen ExAC gnomAD |
|
|
rs1315750637 CA387496622 |
116 | T>A | No |
ClinGen TOPMed gnomAD |
|
|
CA387496713 rs1465282232 |
124 | S>L | No |
ClinGen Ensembl |
|
|
CA387496734 rs1408637048 |
126 | K>R | No |
ClinGen TOPMed |
|
| TCGA novel | 128 | Q>H | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs1481314861 CA387496824 |
135 | I>V | No |
ClinGen gnomAD |
|
|
CA387496840 rs1565987160 |
137 | I>M | No |
ClinGen Ensembl |
|
|
CA246592776 rs762471125 |
137 | I>V | No |
ClinGen Ensembl |
|
|
CA246592777 rs373878914 |
139 | P>A | No |
ClinGen ESP |
|
|
CA6907767 rs748207834 |
139 | P>L | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA6907768 rs755534247 |
141 | N>H | No |
ClinGen ExAC gnomAD |
|
|
rs1395783276 CA387496869 |
143 | A>T | No |
ClinGen Ensembl |
|
|
rs1804867 CA246592799 |
144 | P>L | No |
ClinGen gnomAD |
|
|
CA6907771 rs201976008 |
145 | P>L | No |
ClinGen 1000Genomes ExAC gnomAD |
|
|
rs752761827 CA6907770 |
145 | P>S | No |
ClinGen ExAC gnomAD |
|
|
CA246592846 rs17852855 |
146 | P>T | No |
ClinGen Ensembl |
|
|
rs146801945 CA246592853 |
147 | S>P | No |
ClinGen ESP TOPMed gnomAD |
|
|
CA6907774 rs376710499 |
149 | R>H | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ESP ExAC NCI-TCGA TOPMed gnomAD |
|
CA246592893 rs148923843 |
150 | M>L | No |
ClinGen ESP ExAC gnomAD |
|
|
rs148923843 CA6907775 |
150 | M>V | No |
ClinGen ESP ExAC gnomAD |
|
|
CA6907776 rs749228463 |
151 | R>T | No |
ClinGen ExAC gnomAD |
No associated diseases with O00422
No regional properties for O00422
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| No domain, repeats, and functional sites for O00422 | |||
Functions
7 GO annotations of cellular component
| Name | Definition |
|---|---|
| ASAP complex | A protein complex involved in regulation of mRNA processing and apoptosis. It binds to RNA in a sequence-independent manner and is recruited to the EJC prior to or during the splicing process. In humans the core proteins are RNPS1, SAP18 and ACIN1. |
| cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| histone deacetylase complex | A protein complex that possesses histone deacetylase activity. |
| nuclear body | Extra-nucleolar nuclear domains usually visualized by confocal microscopy and fluorescent antibodies to specific proteins. |
| nuclear speck | A discrete extra-nucleolar subnuclear domain, 20-50 in number, in which splicing factors are seen to be localized by immunofluorescence microscopy. |
| nucleoplasm | That part of the nuclear content other than the chromosomes or the nucleolus. |
| nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
2 GO annotations of molecular function
| Name | Definition |
|---|---|
| RNA binding | Binding to an RNA molecule or a portion thereof. |
| transcription corepressor activity | A transcription coregulator activity that represses or decreases the transcription of specific gene sets via binding to a DNA-bound DNA-binding transcription factor, either on its own or as part of a complex. Corepressors often act by altering chromatin structure and modifications. For example, one class of transcription corepressors modifies chromatin structure through covalent modification of histones. A second class remodels the conformation of chromatin in an ATP-dependent fashion. A third class modulates interactions of DNA-bound DNA-binding transcription factors with other transcription coregulators. |
7 GO annotations of biological process
| Name | Definition |
|---|---|
| mRNA processing | Any process involved in the conversion of a primary mRNA transcript into one or more mature mRNA(s) prior to translation into polypeptide. |
| negative regulation of DNA-templated transcription | Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription. |
| negative regulation of mRNA splicing, via spliceosome | Any process that stops, prevents or reduces the rate or extent of mRNA splicing via a spliceosomal mechanism. |
| positive regulation of apoptotic process | Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process. |
| regulation of alternative mRNA splicing, via spliceosome | Any process that modulates the frequency, rate or extent of alternative splicing of nuclear mRNAs. |
| regulation of transcription by RNA polymerase II | Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II. |
| RNA splicing | The process of removing sections of the primary RNA transcript to remove sequences not present in the mature form of the RNA and joining the remaining sections to form the mature form of the RNA. |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MAVESRVTQE | EIKKEPEKPI | DREKTCPLLL | RVFTTNNGRH | HRMDEFSRGN | VPSSELQIYT |
| 70 | 80 | 90 | 100 | 110 | 120 |
| WMDATLKELT | SLVKEVYPEA | RKKGTHFNFA | IVFTDVKRPG | YRVKEIGSTM | SGRKGTDDSM |
| 130 | 140 | 150 | |||
| TLQSQKFQIG | DYLDIAITPP | NRAPPPSGRM | RPY |